Clinical Experience With the Zimmer Trabecular Metal (TM) Glenoid in Total Shoulder Arthroplasty

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

104 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-04-30

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this randomized controlled study is to obtain outcomes data on the Zimmer TM glenoid component by analysis of standard scoring systems and radiographs in comparison to the cemented glenoid component. In addition, the investigators plan to provide cost analysis based on the economic data collected to justify the cost difference between both implants.

Patients with acceptable glenoid bone stock will be randomized into two groups to be treated with either a TM Glenoid or cemented glenoid component with minimum 2 years follow-up; maximum 10 years follow-up.

Hypothesis: The early and long-term clinical outcomes and radiographic analysis of the TM glenoid components are superior to the cemented glenoid components in total shoulder arthroplasty patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cemented vs. Non-Cemented TSA for OA of the Shoulder

NCT00158418

Osteoarthritis

COMPLETED PHASE3

S-11 SMR TT Hybrid Glenoid and Cementless Finned Short Stem

NCT05314387

Shoulder Arthritis Shoulder Osteoarthritis Arthrosis +6 more

NOT_YET_RECRUITING

Patient Reported Outcome After Stemmed Versus Stemless Total Shoulder Arthroplasty for Glenohumeral Osteoarthritis.

NCT03877315

Shoulder Pain Shoulder Osteoarthritis Shoulder Arthritis

UNKNOWN NA

Post-Market Study of Comprehensive Reverse Augmented Glenoid and Mini Humeral Tray in Total Shoulder Arthroplasty

NCT03726554

Arthropathy of Shoulder Region Grossly Deficient Rotator Cuff Osteoarthritis of the Shoulder +2 more

ACTIVE_NOT_RECRUITING NA

Onlay Versus Inlay Humeral Component in Reverse Total Shoulder Arthroplasty

NCT05297305

Arthritis Shoulder Rotator Cuff Injuries

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Total shoulder arthroplasty is successful in relieving pain and restoring function to the joint, but chronic loosening of the glenoid implant remains a common complication. The Zimmer Trabecular Metal (TM) Glenoid is a monoblock implant for reconstructive total shoulder arthroplasty. To date, no published clinical data is available to confirm evidence on the effectiveness of this specific product.

The purpose of this prospective study is to obtain both short and long-term clinical outcomes data on the Zimmer TM Glenoid by analysis of standard scoring systems and radiographic analysis. The TM Glenoid Component is intended to function within Zimmer, Inc.'s Bigliani/Flatow (B/F) Complete Shoulder Solution. The device is a monoblock glenoid component comprised of a Trabecular Metal base, and is designed to interface and articulate with Zimmer, Inc.'s B/F humeral components. The Trabecular Metal Glenoid is designed with an articular surface that is manufactured from ultra-high molecular weight polyethylene (UHMWPE). The base of the implant has a cruciate TM keel that provides stability and initial fixation using a press-fit between the implant and the bone. Long-term fixation is provided by biological ingrowth into the TM material. Surgical fixation of the trabecular metal device will be obtained via press-fit. Surgical fixation of the comparison all-polyethylene glenoid component will be with Palacos/CoPal bone cement

This is a multi-centre, randomized controlled study to evaluate the clinical and radiological performance of the TM Glenoid in a series of patients with adequate glenoid bone stock receiving a total shoulder replacement. The comparison group will be a consecutive series of randomized patients with implanted cemented all-polyethylene glenoid component. This study will be descriptive in nature and seeks to demonstrate the superiority (or non-inferiority) of the TM Glenoid over cemented all-polyethylene glenoid components.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoarthritis of the Shoulder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TM Glenoid

Zimmer TM glenoid shoulder replacement component will be used for the glenoid component of the total shoulder replacement.

Group Type ACTIVE_COMPARATOR

Zimmer TM Glenoid

Intervention Type DEVICE

The Zimmer TM glenoid will be used for the glenoid shoulder replacement component.

Cemented Glenoid

Cemented glenoid shoulder replacement component

Group Type ACTIVE_COMPARATOR

Cemented Glenoid

Intervention Type DEVICE

A cemented glenoid will be used for the glenoid component of the total shoulder replacement.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Zimmer TM Glenoid

The Zimmer TM glenoid will be used for the glenoid shoulder replacement component.

Intervention Type DEVICE

Cemented Glenoid

A cemented glenoid will be used for the glenoid component of the total shoulder replacement.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Zimmer Trabecular Metal Glenoid Cemented all-polyethylene glenoid component (Zimmer)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age - 18 years minimum and 80 years of age maximum.
* Gender - male and female.
* Primary Diagnosis: Primary Glenohumeral Osteoarthritis
* Informed Consent - patient has signed a 'Patient Informed Consent form'
* Surgery date: Beginning on January 1, 2012

Exclusion Criteria

* Age \> 80 years
* Significant Bone Loss (classified as concentric vs eccentric; contained vs uncontained) on pre-operative CT scan requiring cemented prosthesis.
* Evidence of major joint trauma, infection, avascular necrosis, cuff tear arthropathy, inflammatory arthropathy, chronic dislocation, massive rotator cuff tear or previous shoulder surgery (other than arthroscopic debridement)
* Preoperative computed tomography scans of the shoulder that showed insufficient glenoid bone stock to allow for implantation of a glenoid prosthesis
* Active joint or systematic infection, significant muscle paralysis, or Charcot arthropathy
* Life expectancy of less than 2 years or unacceptably high operative risk
* Inability to speak or read English
* Psychiatric illness or cognitive deficit that precluded informed consent
* Unwillingness to be followed up for 5 years

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No